Karyopharm Therapeutics KPTI
NASDAQ KPTI
$0.53 +0.10 (+24.13%)
As of: Oct 22, 2026 · 12:41 PM EDT

Karyopharm Therapeutics (KPTI) Debt Ratio (2024 - 2026)

Updated

Karyopharm Therapeutics' (KPTI) Debt Ratio came in at 1.13 for Q2 2026, up 23.3% from 0.91 a year earlier.

Analysis

Karyopharm Therapeutics (KPTI) Debt Ratio (2024 - 2026) Analysis & Trends

For FY2025, Karyopharm Therapeutics' Debt Ratio stood at 1.07, up 85.6% from FY2024.

  • In prior years, Karyopharm Therapeutics' Debt Ratio was 0.58 in FY2024.
  • The Q2 2026 figure stands as the highest quarterly Debt Ratio in data going back to Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,168.95 Bn 1,137.53 Bn 19.71 Bn 0.39
2 Johnson & Johnson 642.08 Bn 560.60 Bn 17.26 Bn 0.24
3 AbbVie 500.03 Bn 473.14 Bn 12.70 Bn 0.52
4 Merck 359.04 Bn 313.42 Bn 12.21 Bn 0.42
5 Novartis Ag 301.98 Bn 265.97 Bn 11.24 Bn 0.08
6 Astrazeneca 267.05 Bn 240.74 Bn 12.86 Bn 0.28
7 Amgen 241.60 Bn 197.00 Bn 7.24 Bn 0.60
8 Gilead Sciences 192.44 Bn 166.64 Bn 6.22 Bn 0.53
9 Pfizer 171.37 Bn 118.01 Bn 10.94 Bn 0.31
10 Karyopharm Therapeutics 15.22 Mn -211.20 Mn 32.35 Mn 1.13
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.13
Dec 31, 2025 1.07
Sep 30, 2025 1.00
Jun 30, 2025 0.91
Mar 31, 2025 0.75
Dec 31, 2024 0.58
Sep 30, 2024 0.50
Jun 30, 2024 0.44
API Access

Karyopharm Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=KPTI&period=max&api_key=YOUR_API_KEY